Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging Cohort

Conclusions Results from the ISR imaging cohort demonstrate high patency and a low rate of CD TLR at 12 months. These data confirm the safety and effectiveness of the IN.PACT Admiral DCB (Medtronic, Dublin, Ireland) in complex femoropopliteal lesions, including this challenging subset.

http://www.interventions.onlinejacc.org/cgi/content/short/10/20/2113?rss=1

Source: Journal of the American College of Cardiology: Cardiovascular Interventions - October 16, 2017 Category: Cardiology Authors: Brodmann, M., Keirse, K., Scheinert, D., Spak, L., Jaff, M. R., Schmahl, R., Li, P., Zeller, T., on behalf of the IN.PACT Global Study Investigators Tags: Peripheral Source Type: research